All featured compounds
Every compound carried over from the former wesyntech.com product centre — 27 in total, grouped exactly as the old site grouped them. The full 672-compound catalogue is searchable separately.
15 compounds
Active Pharmaceutical Ingredients
Named research APIs and clinical-stage actives supplied for reference, analytical and development work. Read the group page →

1307245-86-8CAS 1307245-86-8(2-(4-((2'-Chloro-4',4'-difluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl)methyl)-3-methyl-1H-pyrazol-1-yl)pyridin-3-yl)methanolView compound →

1620278-72-9CAS 1620278-72-91-(4-(Aminomethyl)benzyl)-2-butyl-1H-imidazo[4,5-c]quinolin-4-amine dihydrochlorideView compound →

APD 668CAS 832714-46-2APD668/Isopropyl 4-((1-(2-fluoro-4-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxy)piperidine-1-carboxylateView compound →

EAI 045CAS 1942114-09-1EAI045/N-(3-((5-fluoroethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide(EAI-045)View compound →

FGF 401CAS 1708971-55-4FGF401View compound →

GNF 5837CAS 1033769-28-6GNF5837View compound →

Kira8CAS 1630086-20-2Active Pharmaceutical IngredientsView compound →

NVP-TAE 226CAS 761437-28-9NVP-TAE 226View compound →

PF 9366CAS 72882-78-1PF-9366View compound →

PF-573228CAS 869288-64-2PF-573228View compound →

PFI-2CAS 1627676-59-88-fluoro-1,2,3,4-tetrahydro-N-[(1R)-2-oxo-2-(1-pyrrolidinyl)-1-[[3-(trifluoromethyl)phenyl]methyl]ethyl]-6-isoquinolinesulfonamideView compound →

Ro 46-8443CAS 175556-12-4Ro 46-8443View compound →

RO3CAS 1026582-88-65-[[4,5-Dimethoxy-2-(methylethyl)phenyl]methyl]-2,4-pyrimidinediamineView compound →

SB649868CAS 380899-24-1SB-649868/(S)-N-((1-(5-(4-fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamideView compound →

TAK 799CAS 229005-80-5N,N-Dimethyl-N-(4-(2-(p-tolyl)-6,7-dihydro-5H-benzo[7]annulene-8-carboxamido)benzyl)tetrahydro-2H-pyran-4-aminium chlorideView compound →
7 compounds
Pharmaceutical Intermediates
Key intermediates and starting materials carried forward into API routes. Read the group page →

1082745-53-6CAS 1082745-53-65-amino-1-(4,4-difluorocyclohexyl)-1H-pyrazole-4-carbonitrileView compound →

113664-24-7CAS 113664-24-7N4,N4,N4',N4'-tetrakis(4-bromophenyl)-[1,1'-biphenyl]-4,4'-diamineView compound →

1784402-13-6CAS 1784402-13-6Pharmaceutical IntermediatesView compound →

2-(2-FLUOROBENZYL)PYRROLIDINECAS 383127-84-22-(2-FLUOROBENZYL)PYRROLIDINEView compound →

3-bromo-6,7-dimethoxyquinolineCAS 850352-73-73-bromo-6,7-dimethoxyquinolineView compound →
![Chemical structure of 6,7-Dihydro-5H-pyrrolo[1,2-a]iMidazol-6-ol (CAS 1378606-06-4)](assets/img/1378606-06-4.webp)
6,7-Dihydro-5H-pyrrolo[1,2-a]iMidazol-6-olCAS 1378606-06-46,7-Dihydro-5H-pyrrolo[1,2-a]iMidazol-6-olView compound →

74815-32-0CAS 74815-32-0Pharmaceutical IntermediatesView compound →
5 compounds
Catalogue Building Blocks
Privileged building blocks held in the general catalogue, including compounds announced as kilogram stock. Read the group page →

104010-72-2CAS 104010-72-2(3aS,6aS)-2,2-Dimethyl-2H,3aH,4H,6aH-cyclopenta[d][1,3]dioxol-4-oneView compound →

1245645-20-8CAS 1245645-20-87-(TERT-BUTOXYCARBONYL)-5,6,7,8-TETRAHYDRO-1,7-NAPHTHYRIDINE-3-CARBOXYLIC ACIDView compound →

2,6-DimethoxyanilineCAS 2734-70-52,6-DimethoxyanilineView compound →

429673-82-5CAS 429673-82-5(3S,4S)-tert-butyl 3-(tert-butoxycarbonyl(Methyl)aMino)-4-hydroxypyrrolidine-1-carboxylateView compound →

7-(DIFLUOROMETHYL)-1,2,3,4-TETRAHYDROQUINOLINECAS 1783624-20-37-(DIFLUOROMETHYL)-1,2,3,4-TETRAHYDROQUINOLINEView compound →
Not listed? That is the normal case
The catalogue covers what is already made. Custom synthesis covers the rest — send a structure and a quantity and the team will come back with a route assessment.